Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 28, 2004
Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancerFabio Puglisi, Mauro Mansutti, Giuseppe Aprile, et al.
Melanoma Research|May 26, 2018
Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlationsDonatella Iacono, Marika Cinausero, Lorenzo Gerratana, et al.
The Oncologist|February 4, 2021
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 PandemicGianpiero Fasola, Giacomo Pelizzari, Diego Zara, et al.
Anti-Cancer Drugs|December 2, 2011
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapyManuela Miscoria, Fabrizio Tonetto, Laura Deroma, et al.
Future Oncology (London, England)|March 13, 2018
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapyElena Ongaro, Lorenzo Gerratana, Marika Cinausero, et al.
Future Oncology (London, England)|June 30, 2020
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world studyMarta Bonotto, Debora Basile, Lorenzo Gerratana, et al.
JCO Precision Oncology|March 1, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd TrialIlenia Migliaccio, Dario Romagnoli, Francesca Galardi, et al.
Melanoma Research|July 4, 2023
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenaseGiacomo Pelizzari, Elisa Bertoli, Silvia Buriolla, et al.
Breast (Edinburgh, Scotland)|April 22, 2018
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) surveyMarta Bonotto, Debora Basile, Lorenzo Gerratana, et al.
Cancers|June 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future DirectionsFederico Pravisano, Jacopo Costa, Lorenzo De Marchi, et al.
Pageof 5